Everything below concerns lyophilisation. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-09. Numbers and descriptions here follow the published literature rather than marketing material.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | About 1419.5 Da | Calculated from the fifteen-residue sequence |
| Residue count | 15 amino acids | Single-letter sequence GEPPPGKPADDAGLV |
| Compound class | Synthetic peptide | Produced by solid-phase synthesis |
| Synonyms | BPC 157; pentadecapeptide BPC 157 | Naming varies across suppliers and papers |
| Appearance | White to off-white powder | Typical form of the lyophilized material |
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
238U(22Ne,xn)260−xNo (x=4,5,6) This reaction was first studied in 1964 at FLNR. The team were able to detect decays from 252Fm and 250Fm. The 252Fm activity was associated with an ~8 s half-life and assigned to 256102 from the 4n channel, with a yield of 45 nb. They were also able to detect a 10 s spontaneous fission activity also tentatively assigned to 256102. Further work in 1966 on the reaction examined the detection of 250Fm decay using chemical separation and a parent activity with a half-life of ~50 s was reported and correctly assigned to 254102. They also detected a 10 s spontaneous fission activity tentatively assigned to 256102. The reaction was used in 1969 to study some initial chemistry of nobelium at the FLNR. They determined eka-ytterbium properties, consistent with nobelium as the heavier homologue. In 1970, they were able to study the SF properties of 256No. In 2002, Patin et al. reported the synthesis of 256No from the 4n channel but were unable to detect 257No. The cross section values for the 4-6n channels have also been studied at the FLNR.
=== Skin and circulation === Rattlesnakes, like other members of the Squamata order, have a circulatory system that is powered by a three-chambered heart composed of two atria and one ventricle. The right atrium receives deoxygenated blood from veins coming from the systemic circuit. The left atrium receives oxygenated blood from the lungs in the pulmonary circuit and pumps it to the ventricle and through the systemic circuit via capillaries and arteries. Rattlesnake skin has a set of overlapping scales that cover the entire body, providing protection from a variety of threats, including dehydration and physical trauma. The typical rattlesnake, genus Crotalus, has the top of its head covered with small scales, except, with a few species, a few crowded plates directly over the snout. The skin of snakes is highly sensitive to contact, tension, and pressure; they are capable of feeling pain. An important function of the skin is the sensation of changes in air temperature, which can guide the snakes towards warm basking/shelter locations. All snakes are ectotherms. To maintain a stable body temperature, they exchange heat with their external environments. Snakes often move into open, sunny areas to absorb heat from the sun and warmed earth, a behavior known as basking. Nerves in the skin regulate the flow of blood into the veins near the surface. The skin of rattlesnakes is intricately patterned in a manner that camouflages them from their predators.
== Further reading == Tai CH, Lee NC, Chien YH, Byrne BJ, Muramatsu SI, Tseng SH, et al. (February 2022). "Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency". Molecular Therapy. 30 (2): 509–518. doi:10.1016/j.ymthe.2021.11.005. PMC 8822132. PMID 34763085.{{cite journal}}: CS1 maint: overridden setting (link)
Sources: en.wikipedia.org
=== Related terminology === The rate of a reaction is the concentration of substrate disappearing (or product produced) per unit time (mol L−1 s−1). The % purity is 100% × (specific activity of enzyme sample / specific activity of pure enzyme). The impure sample has lower specific activity because some of the mass is not actually enzyme. If the specific activity of 100% pure enzyme is known, then an impure sample will have a lower specific activity, allowing purity to be calculated and then getting a clear result.
== Symptoms and signs == For reasons that are not understood, many people with defective variants of the AMPD genes are asymptomatic, while others have symptoms including exercise intolerance, and/or muscle pain and cramping.
== Current status == In October 1998, the United States Navy fleet of E-6Bs replaced the EC-135C in performing the "Looking Glass" mission, previously carried out for 37 years by the U.S. Air Force. Unlike the original Looking Glass aircraft, the E-6Bs are modified Boeing 707 aircraft, not the military-only KC-135. The E-6B provides the National Command Authority with the same capability as the EC-135 fleet to control the nation's intercontinental ballistic missile (ICBM) force, nuclear-capable bombers and submarine-launched ballistic missiles (SLBM). With the assumption of this mission, a USSTRATCOM battle staff now flies with the TACAMO crew. If the USSTRATCOM Global Operations Center (GOC) is unable to function in its role, the E-6B Looking Glass can assume command of all U.S. nuclear-capable forces. Flying aboard each ABNCP is a crew of 22, which includes an air crew, a Communications Systems Officer and team, an Airborne Emergency Action Officer (an Admiral or General officer), a Mission Commander, a Strike Advisor, an Airborne Launch Control System/Intelligence Officer, a Meteorological Effects Officer, a Logistics Officer, a Force Status Controller, and an Emergency Actions NCO. In addition to being able to direct the launch of ICBMs using the Airborne Launch Control System, the E-6B can communicate Emergency Action Messages (EAM) to nuclear submarines running at depth, by extending a two and a half-mile-long (4 km) trailing wire antenna (TWA) for use with the Survivable Low Frequency Communications System (SLFCS), as the EC-135C could.
Sources: en.wikipedia.org
Portugal has a literary tradition that predates the Portuguese language going back into the early 13th century. Portuguese literature developed through song as well as the written page known as cantigas. The cantigas drew practitioners from all social ranging from King Denis I to Martin Codax who was a minstrel. The earliest known work of literature produced by a Portuguese is the Ora faz ost'o senhor de Navarra, a cantiga de escárnio e maldizer written in Galician–Portuguese by João Soares de Paiva at around the year 1200. Portuguese literature developed under the influence of both European geopolitical developments and broader European literary traditions. The Hundred Years' War helped foster the development of Portuguese chronicles by Fernão Lopes, which constitute a valuable record of some of Europe's early encounters with peoples beyond the continent. European medieval chivalric literature, together with didactic religious literature transmitted through adaptations and partial translations, contributed to the development of Portuguese poetry in the translated works of Norman French Arturian narratives. Portuguese literature flourished during the Age of Discovery with writers such as Luís Vaz de Camões and António Ferreira. Modern Portuguese literature took shape through the work of Almeida Garrett, one of the founders of Portuguese Romanticism. Portugal has one Nobel Prize–winning author—José Saramago (1998).
== Side effects == Common adverse reactions include nausea, headache, fatigue, vomiting, diarrhea, Anorexia (symptom) (loss of appetite), and insomnia (trouble sleeping). Rare but serious side effects include hypersensitivity reaction such as rash, elevated AST and ALT, depression, anxiety, fever/chills, URI, lactic acidosis, hypertriglyceridemia, and lipodystrophy.
== Adverse effects == Torsades de pointes is the most serious side effect of dofetilide therapy. The incidence of torsades de pointes is 0.3-10.5% and is dose-related, with increased incidence associated with higher doses. The majority of episodes of torsades de pointes have occurred within the first three days of initial dosing. Patients should be hospitalized and monitored for the first three days after starting dofetilide. The risk of inducing torsades de pointes can be decreased by taking precautions when initiating therapy, such as hospitalizing individuals for a minimum of three days for serial creatinine measurement, continuous telemetry monitoring and availability of cardiac resuscitation.
The diagram shows a simplified decay scheme of 60Co and 60mCo. The main β-decay transitions are shown. The probability for population of the middle energy level of 2.1 MeV by β-decay is only 0.0022%, with a β-energy of 0.67 MeV. Transitions between the three levels generate six different gamma-ray frequencies. In the diagram the two important ones are marked. Internal conversion is not significant. The half-value and 1/10th value layer thickness for shielding against this isotope's radiations has been determined for different materials:
Sources: en.wikipedia.org
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.
The number is an internal laboratory designation from the research group that first described the fragment. It does not encode a molecular weight, a receptor target, or a measured biological effect, and it carries no meaning outside the naming history of the compound.
It contains fifteen amino acid residues and has a calculated mass of roughly 1419.5 daltons. That places it in the short-peptide range, well below the size of small proteins, which affects how it is synthesized, purified, and analyzed.
Reversed-phase liquid chromatography with ultraviolet detection gives a purity estimate, while mass spectrometry confirms molecular mass and flags modifications. Amino acid analysis can add compositional confirmation. Results are most meaningful when a validated reference standard is run alongside the sample.